Literature DB >> 19200784

Anion channels in Plasmodium-falciparum-infected erythrocytes and protein kinase A.

Anaïs Merckx1, Guillaume Bouyer, Serge L Y Thomas, Gordon Langsley, Stéphane Egée.   

Abstract

By replicating within red blood cells, malaria parasites are largely hidden from immune recognition; however, in the cells, nutrients are limiting and hazardous metabolic end products can rapidly accumulate. Therefore, to survive within erythrocytes, parasites alter the permeability of the host plasma membrane, either by upregulating existing transporters or by creating new permeation pathways. Recent electrophysiological studies of Plasmodium-infected erythrocytes have demonstrated that membrane permeability is mediated by transmembrane transport through ion channels in the infected erythrocyte. This article discusses the evidence and controversies concerning the nature of these channels and surveys the potential role of phosphorylation in activating anion channels that could be important in developing novel strategies for future malarial chemotherapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200784     DOI: 10.1016/j.pt.2008.12.005

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  14 in total

1.  Structure of yeast regulatory subunit: a glimpse into the evolution of PKA signaling.

Authors:  Jimena Rinaldi; Jian Wu; Jie Yang; Corie Y Ralston; Banumathi Sankaran; Silvia Moreno; Susan S Taylor
Journal:  Structure       Date:  2010-11-10       Impact factor: 5.006

Review 2.  The malaria parasite Plasmodium falciparum: cell biological peculiarities and nutritional consequences.

Authors:  Stefan Baumeister; Markus Winterberg; Jude M Przyborski; Klaus Lingelbach
Journal:  Protoplasma       Date:  2009-11-25       Impact factor: 3.356

3.  A CLAG3 mutation in an amphipathic transmembrane domain alters malaria parasite nutrient channels and confers leupeptin resistance.

Authors:  Paresh Sharma; Kempaiah Rayavara; Daisuke Ito; Katherine Basore; Sanjay A Desai
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

4.  Structural and evolutionary divergence of cyclic nucleotide binding domains in eukaryotic pathogens: Implications for drug design.

Authors:  Smita Mohanty; Eileen J Kennedy; Friedrich W Herberg; Raymond Hui; Susan S Taylor; Gordon Langsley; Natarajan Kannan
Journal:  Biochim Biophys Acta       Date:  2015-04-03

5.  Long-wavelength fluorescent reporters for monitoring protein kinase activity.

Authors:  Nathan P Oien; Luong T Nguyen; Finith E Jernigan; Melanie A Priestman; David S Lawrence
Journal:  Angew Chem Int Ed Engl       Date:  2014-03-06       Impact factor: 15.336

Review 6.  PKA and Apicomplexan Parasite Diseases.

Authors:  M Haidar; G Ramdani; E J Kennedy; G Langsley
Journal:  Horm Metab Res       Date:  2016-11-11       Impact factor: 2.936

7.  Fluorescent Nitrogen-Doped Carbon Dots for Label Live Elder Blood-Stage Plasmodium falciparum through New Permeability Pathways.

Authors:  Jiahui Xu; Fengyue Hu; Shuang Li; Jiaojiao Bao; Yi Yin; Zhenyu Ren; Ying Deng; Fang Tian; Guangyu Bao; Jian Liu; Yinyue Li; Xinlong He; Juqun Xi; Feng Lu
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

Review 8.  Exploring the Plasmodium falciparum cyclic-adenosine monophosphate (cAMP)-dependent protein kinase (PfPKA) as a therapeutic target.

Authors:  Nina M Haste; Hana Talabani; Alex Doo; Anais Merckx; Gordon Langsley; Susan S Taylor
Journal:  Microbes Infect       Date:  2012-05-22       Impact factor: 2.700

9.  The survival strategies of malaria parasite in the red blood cell and host cell polymorphisms.

Authors:  Gunanidhi Dhangadamajhi; Shantanu Kumar Kar; Manoranjan Ranjit
Journal:  Malar Res Treat       Date:  2010-08-19

10.  The Stapled AKAP Disruptor Peptide STAD-2 Displays Antimalarial Activity through a PKA-Independent Mechanism.

Authors:  Briana R Flaherty; Yuxiao Wang; Edward C Trope; Tienhuei G Ho; Vasant Muralidharan; Eileen J Kennedy; David S Peterson
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.